BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32319390)

  • 1. [Efficacy and Safety of Intensive Maintenance Chemotherapy Regimen for Treatment of Children and Adolescents with Lymphoblastic Lymphoma for Stage III-IV].
    Liu YF; Liu SW; Sun XJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):524-528. PubMed ID: 32319390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of modified BFM-90 regimen on children and adolescents with T cell lymphoblastic lymphoma: a report of 20 cases].
    Sun XF; Jiang WQ; Liu DG; Xia ZJ; Huang HQ; Zhang L; Li YH; Zhou ZM; Zhen ZJ; Xia Y; He YJ; Guan ZZ
    Ai Zheng; 2004 Dec; 23(12):1687-91. PubMed ID: 15601561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and Prognostic analysis of 43 Children with Mature B-cell Non-Hodgkin's Lymphoma/Acute Lymphoblastic Leukemia].
    Guo J; Zhu YP; Gao J; Li Q; Jia CS; Zhou CY; Guo X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):72-9. PubMed ID: 26913397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of treatment of lymphoblastic lymphoma at the children cancer hospital Egypt - A single center experience.
    Rahman Sayed HA; Sedky M; Hamoda A; Kinaaie NE; Wakeel ME; Hesham D
    J Egypt Natl Canc Inst; 2016 Sep; 28(3):175-81. PubMed ID: 27339800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparing CHOP, CHOP+HD-MTX,and BFM-90 regimens in the survival rate of children and adolescents with B cell non-Hodgkin's lymphoma].
    Sun XF; Su YS; Liu DG; Jiang WQ; He YJ; Lin TY; Huang HQ; Zhang L; Xia ZJ; Li YH; Zhou ZM; Chen XQ; Xia Y; Zhen ZJ; Guan ZZ
    Ai Zheng; 2004 Aug; 23(8):933-8. PubMed ID: 15301718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A collaborative study of children with lymphoblastic non-Hodgkin's lymphoma in China].
    ;
    Zhonghua Er Ke Za Zhi; 2015 Dec; 53(12):931-7. PubMed ID: 26887549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensive chemotherapy improved treatment outcome for Chinese children and adolescents with lymphoblastic lymphoma.
    Sun XF; Xia ZJ; Zhen ZJ; Xiang XJ; Xia Y; Ling JY; Liu DG; Huang HQ; Zhen L; Luo WB; Lin H; Guan ZZ
    Int J Clin Oncol; 2008 Oct; 13(5):436-41. PubMed ID: 18946754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Outcomes of modified NHL-BFM-90 protocol for children and adolescents with lymphoblastic lymphoma].
    Sun X; Zhen Z; Zhu J; Wang J; Lu S; Xia Y; Sun F; Chen Y; Zhang F; Cai R; Li P; Guo X
    Zhonghua Xue Ye Xue Za Zhi; 2014 Dec; 35(12):1083-9. PubMed ID: 25543702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Impact of Intensified Maintenance Therapy on Children With Advanced Lymphoblastic Lymphoma: A Report From the Japanese Pediatric Leukemia/Lymphoma Study Group ALB-NHL03 Study.
    Sunami S; Sekimizu M; Takimoto T; Mori T; Mitsui T; Fukano R; Saito AM; Watanabe T; Ohshima K; Fujimoto J; Nakazawa A; Kobayashi R; Horibe K; Tsurusawa M
    Pediatr Blood Cancer; 2016 Mar; 63(3):451-7. PubMed ID: 26585702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of the efficacy of CCCG-97 and BFM-90 protocols in the treatment for children with mature B-cell non-Hodgkin's lymphoma].
    Meng JH; Gao YJ; Lu FJ; Zhai XW; Wang HS; Li J
    Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):222-7. PubMed ID: 22780979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical Efficacy of ALL-2005 and ALL-2009 Regimen and Factors Influencing Prognosis of Newly Diagnosed ALL Patients Aged between 10-18 Years Old].
    Li X; Si SY; Cai JJ; Qu WJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec; 28(6):1904-1911. PubMed ID: 33283718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Favorable outcome for children and adolescents with T-cell lymphoblastic lymphoma with an intensive ALL-type therapy without local radiotherapy.
    Grenzebach J; Schrappe M; Ludwig WD; Parwaresch R; Zimmermann M; Gadner H; Riehm H; Reiter A;
    Ann Hematol; 2001; 80 Suppl 3():B73-6. PubMed ID: 11757713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inferior outcomes of stage III T lymphoblastic lymphoma relative to stage IV lymphoma and T-acute lymphoblastic leukemia: long-term comparison of outcomes in the JACLS NHL T-98 and ALL T-97 protocols.
    Kobayashi R; Takimoto T; Nakazawa A; Fujita N; Akazai A; Yamato K; Yazaki M; Deguchi T; Hashii Y; Kato K; Hatakeyama N; Horibe K; Hori H; Oda M;
    Int J Hematol; 2014 Jun; 99(6):743-9. PubMed ID: 24803201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Impact of intensified maintenance therapy on the prognosis of children and adolescents with advanced lymphoblastic lymphoma].
    Yang KB; Sun XF; Zhen ZZ; Lu SY; Zhu J; Sun FF; Wang J; Huang JT; Chen RR; Ye LT; Liu Y; You ZY
    Zhonghua Xue Ye Xue Za Zhi; 2017 Sep; 38(9):778-783. PubMed ID: 29081195
    [No Abstract]   [Full Text] [Related]  

  • 15. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
    Güneş AM; Oren H; Baytan B; Bengoa SY; Evim MS; Gözmen S; Tüfekçi O; Karapınar TH; Irken G
    Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical effect of CCLG-ALL2008 regimen in treatment of children and adolescents aged >10 years with acute lymphoblastic leukemia].
    Lan Y; Chen XJ; Zou Y; Ruan M; Zhu XF
    Zhongguo Dang Dai Er Ke Za Zhi; 2019 May; 21(5):405-410. PubMed ID: 31104652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of Modified LMB 89± Rituximab Regimen on Long-Term Benefits for Patients's with Burkitt Lymphoma].
    Tan L; Xie Y; Yang J; Liu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):872-875. PubMed ID: 32552950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy of modified B-NHL-BFM-90 protocol on Burkitt's lymphoma in Chinese children and adolescents].
    Sun XF; Zhen ZJ; Liu DG; Xia Y; Xiang XJ; Chen XQ; Ling JY; Zheng L; Luo WB; Lin H; He YJ; Guan ZZ
    Ai Zheng; 2007 Dec; 26(12):1339-43. PubMed ID: 18076797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol: the 30-year experience at Memorial-Sloan-Kettering Cancer Center.
    Mora J; Filippa DA; Qin J; Wollner N
    Cancer; 2003 Sep; 98(6):1283-91. PubMed ID: 12973853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment outcome of childhood standard-risk and median-risk acute lymphoblastic leukemia with CCLG-2008 protocol].
    Liu X; Zou Y; Wang H; Chen X; Ruan M; Chen Y; Yang W; Guo Y; Liu T; Zhang L; Wang S; Zhang J; Liu F; Cai X; Qi B; Chang L; Zhu X
    Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):449-54. PubMed ID: 25190166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.